|
US5986054A
(en)
*
|
1995-04-28 |
1999-11-16 |
The Hospital For Sick Children, Hsc Research And Development Limited Partnership |
Genetic sequences and proteins related to alzheimer's disease
|
|
JP5379119B2
(ja)
*
|
1995-04-28 |
2013-12-25 |
エイチエスシー リサーチ アンド ディベロップメント リミテッド |
アルツハイマー病に関連する遺伝子配列およびタンパク質、ならびにその使用
|
|
US6531586B1
(en)
|
1995-04-28 |
2003-03-11 |
The Hospital For Sick Children |
Genetic sequences related to Alzheimer's Disease
|
|
US6210919B1
(en)
|
1995-04-28 |
2001-04-03 |
Hsc Research And Development Limited Partnership |
Genetic sequences and proteins related to alzheimer's disease
|
|
WO1997007213A2
(en)
*
|
1995-08-16 |
1997-02-27 |
President And Fellows Of Harvard College |
Assay for identifying genes causing chromosome non-disjunction
|
|
JP2000506375A
(ja)
*
|
1996-01-26 |
2000-05-30 |
エイチエスシー リサーチ アンド デベロップメント リミテッド パートナーシップ |
アルツハイマー病に関連する核酸およびタンパク質、ならびにその使用
|
|
ES2128265B1
(es)
*
|
1997-06-04 |
2000-03-01 |
Euroespes S A |
Kit genetico para la caracterizacion molecular de la enfermedad de alzheimer.
|
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
|
US7790856B2
(en)
|
1998-04-07 |
2010-09-07 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
|
US7588766B1
(en)
|
2000-05-26 |
2009-09-15 |
Elan Pharma International Limited |
Treatment of amyloidogenic disease
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US20080050367A1
(en)
|
1998-04-07 |
2008-02-28 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
|
US6761888B1
(en)
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
|
WO1999035501A1
(en)
|
1998-01-09 |
1999-07-15 |
The Governing Council Of The University Of Toronto |
Presenilin protein interactions
|
|
TWI255272B
(en)
|
2000-12-06 |
2006-05-21 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
|
US7700751B2
(en)
|
2000-12-06 |
2010-04-20 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize β-amyloid peptide
|
|
JP2003018991A
(ja)
*
|
2001-06-27 |
2003-01-21 |
Japan Science & Technology Corp |
プレセニリン−２遺伝子エキソン５欠損型スプライシング異常の生成に関与する核酸
|
|
MY139983A
(en)
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
|
TWI306458B
(en)
|
2003-05-30 |
2009-02-21 |
Elan Pharma Int Ltd |
Humanized antibodies that recognize beta amyloid peptide
|
|
ES2396555T3
(es)
|
2004-12-15 |
2013-02-22 |
Janssen Alzheimer Immunotherapy |
Anticuerpos que reconocen péptido beta amiloide
|
|
ES2434732T3
(es)
|
2004-12-15 |
2013-12-17 |
Janssen Alzheimer Immunotherapy |
Anticuerpos para beta-amiloide humanizados para su uso en mejorar la cognición
|
|
US8784810B2
(en)
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
|
JP5124569B2
(ja)
*
|
2006-06-12 |
2013-01-23 |
カー−バー インヴェストメンツ インコーポレイテッド |
ノズル検査装置および方法
|
|
US8003097B2
(en)
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
|
SI2182983T1
(sl)
|
2007-07-27 |
2014-09-30 |
Janssen Alzheimer Immunotherapy |
Zdravljenje amiloidogenih bolezni s humaniziranimi protitelesi proti abeta
|
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
|
US9067981B1
(en)
|
2008-10-30 |
2015-06-30 |
Janssen Sciences Ireland Uc |
Hybrid amyloid-beta antibodies
|
|
WO2013092052A1
(en)
*
|
2011-12-20 |
2013-06-27 |
Unilever Plc |
Isotropic liquid detergents comprising soil release polymer
|
|
WO2019023247A1
(en)
|
2017-07-25 |
2019-01-31 |
Immutics, Inc. |
TREATMENT OF CANCER BY BLOCKING THE INTERACTION OF TIM-3 AND ITS LIGAND
|
|
EP3918323A4
(en)
|
2019-01-30 |
2022-12-28 |
TrueBinding, Inc. |
ANTI-GAL3 ANTIBODIES AND USES THEREOF
|
|
WO2021242776A2
(en)
|
2020-05-26 |
2021-12-02 |
Truebinding, Inc. |
Methods of treating inflammatory diseases by blocking galectin-3
|